Zobrazeno 1 - 10
of 90
pro vyhledávání: '"Stephanie, Noviello"'
Autor:
Ulrich A Walker, Jasmin B Kuemmerle-Deschner, Jeremy Levy, Eleni Vritzali, Hal M Hoffman, Tom van der Poll, PHILIP N HAWKINS, Hugh H Tilson, Stephanie Noviello
Publikováno v:
RMD Open, Vol 7, Iss 2 (2021)
Objective To report the long-term safety and effectiveness of canakinumab, a fully human anti-interleukin 1β monoclonal antibody, in patients with cryopyrin-associated periodic syndromes (CAPS), including familial cold autoinflammatory syndrome (FCA
Externí odkaz:
https://doaj.org/article/5a7617904f374234acba1f6d7e2849d6
Autor:
Cheryl Keech, Vicki E Miller, Barbara Rizzardi, Christopher Hoyle, Melinda J Pryor, Jonathan Ferrand, Ken Solovay, Marcel Thalen, Stephanie Noviello, Peter Goldstein, Andrew Gorringe, Breeze Cavell, Qiushui He, Alex-Mikael Barkoff, Keith Rubin, Camille Locht
Publikováno v:
The Lancet. 401:843-855
Publikováno v:
Rheumatology and Therapy. 9:753-762
Systemic juvenile idiopathic arthritis (sJIA) and adult-onset Still's disease (AOSD) represent pediatric and adult variants of the Still's disease continuum. To determine whether clinical outcomes between patients with sJIA and AOSD were similar, Bay
Autor:
C. Buddy Creech, Natalia Jimenez-Truque, Naomi Kown, Katherine Sokolow, Eric J. Brady, Sandra Yoder, Ken Solovay, Keith Rubin, Stephanie Noviello, Elizabeth Hensel, Semhal Selamawi, Adetunji Bakare, Mat Makowski, Kristina Lu
Publikováno v:
Vaccine. 40(47)
BPZE1 is a live, attenuated pertussis vaccine derived from B. pertussis strain Tohama I modified by genetic removal or inactivation of 3 B. pertussis toxins: pertussis toxin, dermonecrotic toxin, and tracheal cytotoxin. This Phase 2a study evaluated
Autor:
Stephanie Noviello, David B. Huang
Publikováno v:
Diagnostics, Vol 9, Iss 2, p 37 (2019)
Lower respiratory tract infections (LRTIs) are the leading infectious cause of death and the sixth-leading cause of death overall worldwide. Streptococcus pneumoniae, with more than 90 serotypes, remains the most common identified cause of community-
Externí odkaz:
https://doaj.org/article/f4460bd64efb4e99969e1ce79d77fe50
Autor:
Thomas P. Lodise, Thomas L. Holland, G. Ralph Corey, Barbara Balser, William O'Riordan, Antoni Torres, David B. Huang, Stephanie Noviello, Matthew Dryden, Thomas M. File, Amy Scaramucci, Mark H. Wilcox
Publikováno v:
Journal of Medical Microbiology. 69:625-630
Introduction. Iclaprim is a diaminopyrimidine antibiotic for the treatment of acute bacterial skin and skin structure infections (ABSSSI) due to Gram-positive pathogens. Aim. This analysis evaluates patients with wound infections from two Phase 3 tri
Autor:
Roberto, Caricchio, Antonio, Abbate, Ivan, Gordeev, Jamie, Meng, Priscilla Y, Hsue, Tuhina, Neogi, Roberto, Arduino, Daria, Fomina, Roman, Bogdanov, Tatiana, Stepanenko, Pilar, Ruiz-Seco, Andrés, Gónzalez-García, Yu, Chen, Yuhan, Li, Sarah, Whelan, Stephanie, Noviello, George, Wohlford
Publikováno v:
JAMA
IMPORTANCE: Effective treatments for patients with severe COVID-19 are needed. OBJECTIVE: To evaluate the efficacy of canakinumab, an anti–interleukin-1β antibody, in patients hospitalized with severe COVID-19. DESIGN, SETTING, AND PARTICIPANTS: T
Autor:
Kevin S. Griffith, Paul S. Mead, Gregory L. Armstrong, John A. Painter, Katherine A. Kelley, Alex R. Hoffmaster, Donald Mayo, Diane Barden, Renee Ridzon, Umesh D. Parashar, Eyasu Habtu Teshale, Jen Williams, Stephanie Noviello, Joseph F. Perz, Eric E. Mast, David L. Swerdlow, James L. Hadler
Publikováno v:
Emerging Infectious Diseases, Vol 9, Iss 6, Pp 681-688 (2003)
On November 20, 2001, inhalational anthrax was confirmed in an elderly woman from rural Connecticut. To determine her exposure source, we conducted an extensive epidemiologic, environmental, and laboratory investigation. Molecular subtyping showed th
Externí odkaz:
https://doaj.org/article/80d342960cc24d5a91e256814c72c050
Publikováno v:
Clinical Therapeutics. 41:1090-1096
Purpose This analysis evaluates the efficacy and safety of iclaprim versus vancomycin for the treatment of acute bacterial skin and skin structure infections (ABSSSIs) in patients who were intravenous drug users (IVDUs). Methods A total of 621 patien
Autor:
Florence Wong, Alexander Wong, Fiona McPhee, Misti Linaberry, Stephanie Noviello, Wayne Ghesquiere, Gregory D Huhn, Fred Poordad, Rong Yang, Stephen D. Shafran, Mitchell L. Shiffman, Alnoor Ramji
Publikováno v:
Antiviral Therapy. 24:35-44
Background Optimal treatment for patients with HCV genotype-3 infection and liver cirrhosis remains a medical priority. Daclatasvir+sofosbuvir and ribavirin is a recommended option for such patients, but clinical trial data are lacking for treatment